BioCentury
ARTICLE | Company News

MediGene strikes oncology deal

August 17, 2001 7:00 AM UTC

Cancer and cardiovascular play MediGene (NMarkt:MDG) signed an exclusive option to license chemotherapy-related intellectual property from the Memorial Sloan-Kettering Cancer Center (New York, N.Y.). ...